AE
aimee e. mattei
EpiVax Inc
United States
Authors
- AS
anja stadtmüller
Department of Internal Medicine I, University Hospital Würzburg
Germany
- AF
anna frey
Department of Internal Medicine I, University Hospital Würzburg
Germany
- AS
anne s. de groot
EpiVax Inc
United States
- AR
audrey re
Tr1X Inc.
United States
- AJ
ayush jain
Institute of Immunology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden
Germany
- BJ
brian j. roberts
EpiVax Inc
United States
- CD
changsheng du
Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopaedic Department of Tongji Hospital, School of Life Sciences and Technology, Tongji University
China
- DL
daniela langenhorst
Institute for Virology and Immunobiology, University of Würzburg
Germany
- DV
daniela verthelyi
Office of Pharmaceutical Quality Research-Division IV, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
United States
- DH
daryl humes
Tr1X Inc.
United States
- FS
fei sun
Department of Respiratory and Critical Care Medicine, The Center for Biomedical Research, National Health Commission (NHC) Key Laboratory of Respiratory Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
China
...
